M

Molecure SA
WSE:MOC

Watchlist Manager
Molecure SA
WSE:MOC
Watchlist
Price: 8.3 PLN 1.97% Market Closed
Market Cap: 167.7m PLN

Intrinsic Value

MOC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MOC stock under the Base Case scenario is 4.34 PLN. Compared to the current market price of 8.3 PLN, Molecure SA is Overvalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MOC Intrinsic Value
4.34 PLN
Overvaluation 48%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Molecure SA

MOC
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MOC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Molecure SA
WSE:MOC
PL
Pharmaceuticals
Market Cap
167.7m PLN
IPO
Apr 19, 2018
PL
Pharmaceuticals
Market Cap
167.7m PLN
IPO
Apr 19, 2018
Price
złfalse
EPS
złfalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MOC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Molecure SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Molecure SA

Current Assets 54.5m
Cash & Short-Term Investments 52.4m
Receivables 637.4k
Other Current Assets 1.5m
Non-Current Assets 54.3m
PP&E 9.9m
Intangibles 44.4m
Efficiency

Free Cash Flow Analysis
Molecure SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Molecure SA

Revenue
360.2k PLN
Cost of Revenue
-2m PLN
Gross Profit
-1.6m PLN
Operating Expenses
-23.3m PLN
Operating Income
-24.9m PLN
Other Expenses
3m PLN
Net Income
-21.9m PLN
Fundamental Scores

MOC Profitability Score
Profitability Due Diligence

Molecure SA's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Declining ROE
Declining ROIC
Negative 1-Year Revenue Growth
17/100
Profitability
Score

Molecure SA's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

MOC Solvency Score
Solvency Due Diligence

Molecure SA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Molecure SA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MOC Price Targets Summary
Molecure SA

Wall Street analysts forecast MOC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOC is 18.62 PLN with a low forecast of 16.67 PLN and a high forecast of 21 PLN.

Lowest
Price Target
16.67 PLN
101% Upside
Average
Price Target
18.62 PLN
124% Upside
Highest
Price Target
21 PLN
153% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Molecure SA
does not pay dividends
Shareholder Yield

Current shareholder yield for MOC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one MOC stock?

The intrinsic value of one MOC stock under the Base Case scenario is 4.34 PLN.

Is MOC stock undervalued or overvalued?

Compared to the current market price of 8.3 PLN, Molecure SA is Overvalued by 48%.

Back to Top